| Trial ID: | L2769 |
| Source ID: | NCT00964262
|
| Associated Drug: |
Sr Exenatide (Pt302)
|
| Title: |
A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: SR Exenatide (PT302)|DRUG: Placebo
|
| Outcome Measures: |
Primary: To evaluate the safety and pharmacokinetics of SR exenatide (PT302) in healthy subjects after a single subcutaneous injection, 8 weeks | Secondary: To examine the effect on glucose control and pharmacodynamic parameters of SR exenatide (PT302) in healthy subjects after a single subcutaneous injection, 8 weeks
|
| Sponsor/Collaborators: |
Sponsor: Peptron, Inc.
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
34
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-08
|
| Completion Date: |
2010-10
|
| Results First Posted: |
|
| Last Update Posted: |
2013-07-19
|
| Locations: |
Clinical Trials Center, Seoul National University Hospital, Seoul, 110-744, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00964262
|
